Stefan Mihaela S, Knee Alexander B, Ready Audrey, Rastegar Vida, Burgher Seaman Jennifer, Gunn Bridget, Shaw Ehryn, Bannuru Raveendhara R
Department of Medicine, Baystate Medical Center, Springfield, Massachusetts, USA
Epidemiology/Biostatistics Research Core, Office of Research, Baystate Medical Ctr, Springfield, MA, USA.
BMJ Support Palliat Care. 2022 Apr 19. doi: 10.1136/bmjspcare-2021-003507.
This meta-analysis aimed to determine the effectiveness of non-physician provider-led palliative care (PC) interventions in the management of adults with advanced illnesses on patient-reported outcomes and advance care planning (ACP).
We included randomised trials and cluster trials published in MEDLINE, EMBASE, CINAHL, PsycINFO, Cochrane Register of Controlled Trials and ClinicalTrials.gov searched until July 2021 that examined individuals ≥18 years with a diagnosis of advanced, life-limiting illness and received a PC intervention led by a non-physician (nurse, advance practitioner or social worker). Our primary outcome was quality of life (QOL), which was extracted as unadjusted or adjusted estimates and measures of variability. Secondary outcomes included anxiety, depression and ACP.
Among the 21 studies (2370 subjects), 13 included patients with cancer, 3 with heart failure, 4 with chronic respiratory disease and 1 with chronic kidney disease. The interventions were diverse and varied with respect to team composition and services offered. For QOL, the standardised mean differences suggested null effects of PC interventions compared with usual care at 1-2 months (0.04; 95% CI=-0.14 to 0.23, n=10 randomised controlled trials (RCTs)) and 6-7 months (0.10; 95% CI=-0.15 to 0.34, n=6 RCTs). The results for anxiety and depression were not significant also. For the ACP, there was a strong benefit for the PC intervention (absolute increase of 0.32% (95% CI=0.06 to 0.57).
In this meta-analysis, PC interventions delivered by non-physician were not associated with improvement in QOL, anxiety or depression but demonstrated an impact on the ACP discussion and documentation.
本荟萃分析旨在确定由非医师提供者主导的姑息治疗(PC)干预措施对晚期疾病成人患者自我报告结局和预先护理计划(ACP)的有效性。
我们纳入了截至2021年7月在MEDLINE、EMBASE、CINAHL、PsycINFO、Cochrane对照试验注册库和ClinicalTrials.gov上发表的随机试验和整群试验,这些试验研究对象为年龄≥18岁、诊断为晚期、危及生命疾病且接受非医师(护士、高级执业护师或社会工作者)主导的PC干预的个体。我们的主要结局是生活质量(QOL),提取其未调整或调整后的估计值及变异度测量值。次要结局包括焦虑、抑郁和ACP。
在21项研究(2370名受试者)中,13项纳入了癌症患者,3项纳入了心力衰竭患者,4项纳入了慢性呼吸系统疾病患者,1项纳入了慢性肾脏病患者。干预措施在团队组成和提供的服务方面多种多样。对于QOL,标准化均数差表明,与常规护理相比,PC干预在1 - 2个月(0.04;95%CI = -0.14至0.23,n = 10项随机对照试验(RCT))和6 - 7个月(0.10;95%CI = -0.15至0.34,n = 6项RCT)时无效应。焦虑和抑郁的结果也不显著。对于ACP,PC干预有显著益处(绝对增加0.32%(95%CI = 0.06至0.57))。
在本荟萃分析中,非医师提供的PC干预与QOL、焦虑或抑郁的改善无关,但对ACP的讨论和记录有影响。